Pushing limits in dyslipidemia management: Novel drug Evinacumab gives promising results dr. Abhimanyu Uppal21 Dec 2020 5:37 PM ISTA new drug target is emerging for the treatment of patients in whom the LDL cholesterol level remains too high despite treatment with existing...
New analysis confirms LDL-C lowering effect of investigational inclisiran: ESC update Hina Zahid1 Sept 2020 11:56 AM ISTEAST HANOVER, N.J. - A post-hoc analysis of pooled data from the Phase III ORION-10 and -11 trials evaluatedthe individual responses of patients on...
PAD patients less likely to take statins despite ASCVD risk Medha Baranwal19 July 2020 9:11 PM ISTUSA: PD patients are less likely to take statins than those with CHD or cerebrovascular disease despite having a high risk for ASCVD events,...
CAC score may help regulate statins in patients with borderline ASCVD risk Medha Baranwal19 July 2020 9:00 PM ISTUSA: CAC score should be used in patients with borderline or intermediate ASCVD risk to assist in the decision of taking or withdrawing statin...
